J. Kennedy Cruickshank
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
J. Kennedy Cruickshank has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Michael Heagerty
Division of Cardiovascular Sciences, University of Manchester, Manchester, UK
1 shared publication - Bernard Clarke
Biomedical Research Centre, Central Manchester NHS Foundation Trust Manchester, UK
1 shared publication - Brian Derby
Department of Materials, University of Manchester, Oxford Road, Manchester M13 9PL, U.K.
1 shared publication - Debora Chirico
Biomedical Research Centre, Central Manchester NHS Foundation Trust Manchester, UK
1 shared publication - Emmanuel Eroume A. Egom
Laboratory of Human Metabolism and Non-Communicable Diseases, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé P.O. Box 13033, Cameroon
1 shared publication - Farzin Fath-Ordoubadi
Biomedical Research Centre, Central Manchester NHS Foundation Trust Manchester, UK
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 4, 130
Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
Background: Ventricular tachyarrhythmias are the most common and often the first manifestation of coronary heart disease and lead to sudden cardiac death (SCD). Early detection/identification of acute myocardial ischaemic injury at risk for malignant ventricular arrhythmias in patients remains an unmet medical need. In the present study, we examined the sphingolipids level after transient cardiac ischaemia following temporary coronary artery occlusion during percutaneous coronary intervention (PCI) in patients and determined the role of sphingolipids level as a novel marker for early detection of human myocardial ischaemic injury. Methods and Results: Venous samples were collected from either the coronary sinus (n = 7) or femoral vein (n = 24) from 31 patients aged 40–73 years-old at 1, 5 min, and 12 h, following elective PCI. Plasma sphingolipids levels were assessed by HPLC. At 1 min coronary sinus levels of sphingosine 1-phosphate (S1P), sphingosine (SPH), and sphinganine (SA) were increased by 314, 115, and 614%, respectively (n = 7), while peripheral blood levels increased by 79, 68, and 272% (n = 24). By 5 min, coronary sinus S1P and SPH levels increased further (720%, 117%), as did peripheral levels of S1P alone (792%). Where troponin T was detectable at 12 h (10 of 31), a strong correlation was found with peak S1P (R2 = 0.818; P < 0.0001). Conclusion: For the first time, we demonstrate the behavior of plasma sphingolipids following transient cardiac ischaemia in humans. The observation supports the important role of sphingolipids level as a potential novel marker of transient or prolonged myocardial ischaemia.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 4, 130
Open AccessSerum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
Background: Ventricular tachyarrhythmias are the most common and often the first manifestation of coronary heart disease and lead to sudden cardiac death (SCD). Early detection/identification of acute myocardial ischaemic injury at risk for malignant ventricular arrhythmias in patients remains an unmet medical need. In the present study, we examined the sphingolipids level after transient cardiac ischaemia following temporary coronary artery occlusion during percutaneous coronary intervention (PCI) in patients and determined the role of sphingolipids level as a novel marker for early detection of human myocardial ischaemic injury. Methods and Results: Venous samples were collected from either the coronary sinus (n = 7) or femoral vein (n = 24) from 31 patients aged 40–73 years-old at 1, 5 min, and 12 h, following elective PCI. Plasma sphingolipids levels were assessed by HPLC. At 1 min coronary sinus levels of sphingosine 1-phosphate (S1P), sphingosine (SPH), and sphinganine (SA) were increased by 314, 115, and 614%, respectively (n = 7), while peripheral blood levels increased by 79, 68, and 272% (n = 24). By 5 min, coronary sinus S1P and SPH levels increased further (720%, 117%), as did peripheral levels of S1P alone (792%). Where troponin T was detectable at 12 h (10 of 31), a strong correlation was found with peak S1P (R2 = 0.818; P < 0.0001). Conclusion: For the first time, we demonstrate the behavior of plasma sphingolipids following transient cardiac ischaemia in humans. The observation supports the important role of sphingolipids level as a potential novel marker of transient or prolonged myocardial ischaemia.
- 9 September 2010
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 23 (5) , 469-470
Commentary on the ‘Healthy Foods North’ intervention programme
- 9 September 2010
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 23 (5) , 469-470
Commentary on the ‘Healthy Foods North’ intervention programme
- 1 January 2010
- Published by Springer Nature in MRS Proceedings
- Vol. 1274
The Effect of Type 1 Diabetes on the Structure and Function of Fibrillin Microfibrils
- 1 January 2010
- Published by Springer Nature in MRS Proceedings
- Vol. 1274
The Effect of Type 1 Diabetes on the Structure and Function of Fibrillin Microfibrils
- 24 August 2009
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 181 (6-7) , 361-362
Pregnancy glycemia to vascular risk: Nonglycemic diabetes?
See related research article by Retnakaran and Shah, page [371][1] Does our concept of type 2 diabetes and its specialty practice need redirecting? Are the well-known vascular complications associated with type 2 diabetes mellitus because of subclinical damage that occurs long before hyperglycemia
- 24 August 2009
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 181 (6-7) , 361-362
Pregnancy glycemia to vascular risk: Nonglycemic diabetes?
See related research article by Retnakaran and Shah, page [371][1] Does our concept of type 2 diabetes and its specialty practice need redirecting? Are the well-known vascular complications associated with type 2 diabetes mellitus because of subclinical damage that occurs long before hyperglycemia
- 1 July 2005
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (7) , 1435-1436
Ethnic differences in microvascular structure and function
- 1 July 2005
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (7) , 1435-1436
Ethnic differences in microvascular structure and function